The goal of this study is to 1)identify and determine the function of the regulatory and structural genes involved in genetic and immunologic mechanisms of tumor progression of squamous cell carcinoma of the upper aerodigestive tract that affect human communication, and 2) determine whether these molecules and mechanisms may serve as potential targets for prevention, diagnosis, or therapy. To identify and determine the role of genes involved in genetic and immunologic mechanisms of tumor progression, the laboratory has developed a murine model of tumor progression of primary and metastatic squamous cell carcinoma. These cell lines are being analyzed using enzyme immunoassays and differential display of differentially expressed messenger RNA to identify immune signaling molecules and other genes that are potentially involved in tumor progression. Human cell lines and tissues are being studied to confirm the relevance of these findings to the pathogenesis of human squamous cell carcinoma of the upper aerodigestive tract. To determine whether these molecules and other immune signaling molecules may serve to regulate or dysregulate host immune defenses, candidate genes will be transfected into target cells from the murine model which do not express the genes to determine if they are necessary or sufficient for the phenotypic differences observed between the primary and metastatic tumor lines. Retroviral constructs are being tested to determine if they provide adequate gene transduction and expression for use as vectors for these genes.

Agency
National Institute of Health (NIH)
Institute
National Institute on Deafness and Other Communication Disorders (NIDCD)
Type
Intramural Research (Z01)
Project #
1Z01DC000016-03
Application #
2571938
Study Section
Special Emphasis Panel (TBS)
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Name
National Institute on Deafness and Other Communication Disorders
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Lu, Hai; Yan, Carol; Quan, Xin Xin et al. (2014) CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer. Neoplasia 16:789-800
Lu, Hai; Yang, Xinping; Duggal, Praveen et al. (2011) TNF-? promotes c-REL/?Np63? interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer. Cancer Res 71:6867-77
Su, Liya; Xu, Guihua; Shen, Jie et al. (2010) Anticancer bioactive peptide suppresses human gastric cancer growth through modulation of apoptosis and the cell cycle. Oncol Rep 23:3-9
Pernas, Francisco G; Allen, Clint T; Winters, Mary E et al. (2009) Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer. Clin Cancer Res 15:2361-72
Wang, Frederick; Arun, Pattatheyil; Friedman, Jay et al. (2009) Current and potential inflammation targeted therapies in head and neck cancer. Curr Opin Pharmacol 9:389-95
Arun, Pattatheyil; Brown, Matthew S; Ehsanian, Reza et al. (2009) Nuclear NF-kappaB p65 phosphorylation at serine 276 by protein kinase A contributes to the malignant phenotype of head and neck cancer. Clin Cancer Res 15:5974-84
King, Kathryn E; Ponnamperuma, Roshini M; Allen, Clint et al. (2008) The p53 homologue DeltaNp63alpha interacts with the nuclear factor-kappaB pathway to modulate epithelial cell growth. Cancer Res 68:5122-31
Chen, Zhong; Yan, Bin; Van Waes, Carter (2008) The Role of the NF-kappaB Transcriptome and Proteome as Biomarkers in Human Head and Neck Squamous Cell Carcinomas. Biomark Med 2:409-426
Poff, Jason A; Allen, Clint T; Traughber, Bryan et al. (2008) Pulsed high-intensity focused ultrasound enhances apoptosis and growth inhibition of squamous cell carcinoma xenografts with proteasome inhibitor bortezomib. Radiology 248:485-91
Allen, Clint; Saigal, Kunal; Nottingham, Liesl et al. (2008) Bortezomib-induced apoptosis with limited clinical response is accompanied by inhibition of canonical but not alternative nuclear factor-{kappa}B subunits in head and neck cancer. Clin Cancer Res 14:4175-85

Showing the most recent 10 out of 50 publications